Area of research
Rheumatology · Genetics
Research interest
Research interests include Medicine, Omalizumab, Placebo, Adverse effect, Angioedema, and Clinical endpoint.
Sustained safety and efficacy of ligelizumab in patients with chronic spontaneous urticaria: A one‐year extension study
Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: A randomized, double-blind, placebo-controlled phase 3 trial
Ligelizumab for Chronic Spontaneous Urticaria